46.16
2.82%
1.265
시간 외 거래:
46.17
0.005
+0.01%
전일 마감가:
$44.90
열려 있는:
$44.11
하루 거래량:
597.74K
Relative Volume:
1.08
시가총액:
$2.19B
수익:
$658.62M
순이익/손실:
$-155.81M
주가수익비율:
-88.78
EPS:
-0.52
순현금흐름:
$40.93M
1주 성능:
+10.47%
1개월 성능:
-4.36%
6개월 성능:
-13.58%
1년 성능:
-7.24%
Azenta Inc Stock (AZTA) Company Profile
명칭
Azenta Inc
전화
(978) 262-2400
주소
200 SUMMIT DRIVE, BURLINGTON
Azenta Inc Stock (AZTA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-02-01 | 재확인 | B. Riley Securities | Buy |
2023-07-19 | 개시 | Raymond James | Mkt Perform |
2023-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-02-09 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2022-03-31 | 재개 | B. Riley Securities | Buy |
2022-03-21 | 개시 | Evercore ISI | Outperform |
모두보기
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta (AZTA) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast - Lelezard
Azenta (NASDAQ:AZTA) Shares Gap UpHere's Why - MarketBeat
Azenta Inc (AZTA) Stock Price Up 9.28% on Nov 4 - GuruFocus.com
Azenta Enhances Board and Reaffirms Growth Strategy - TipRanks
Azenta Enters into Cooperation Agreement with Politan Capital - Marketscreener.com
AZTAAzenta, Inc. Latest Stock News & Market Updates - StockTitan
Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value - StockTitan
Raymond James & Associates Sells 33,843 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Holdings Reduced by Conestoga Capital Advisors LLC - MarketBeat
Dimensional Fund Advisors LP Expands Portfolio with Azenta Inc A - GuruFocus.com
Azenta launches first approved long-read WGS test in US - Investing.com India
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test - StockTitan
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference C - GuruFocus.com
Genewiz From Azenta Life Sciences Celebrates 25 Years Of Advancing Scientific Discoveries At Genewiz Week Event - MSN
Azenta to Participate in the UBS MedTech, Tools and Genomics Sum - GuruFocus.com
Azenta (NASDAQ:AZTA) Sets New 52-Week LowHere's Why - MarketBeat
Allspring Global Investments Holdings LLC Buys 183,040 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta's CFO Herman Cueto sells shares worth $69,669 By Investing.com - Investing.com South Africa
Azenta, Inc. (NASDAQ:AZTA) CFO Sells $69,669.60 in Stock - MarketBeat
Azenta's CFO Herman Cueto sells shares worth $69,669 - Investing.com
Azenta (NASDAQ:AZTA) Sets New 12-Month LowTime to Sell? - MarketBeat
Millennium Management LLC Decreases Stake in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Short Interest Down 10.6% in September - MarketBeat
Direct Colony Sequencing(DCS) Market to See Booming Growth – Eurofins Genomics, Azenta Life Sciences(GENEWIZ), 1st BASE – elektrotransports.lv - Elektrotransports.lv
Metric Analysis: Azenta Inc (AZTA)’s Key Ratios in the Limelight - The Dwinnex
Truist Financial Corp Sells 14,403 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta (NASDAQ:AZTA) Reaches New 12-Month LowHere's What Happened - MarketBeat
Thrivent Financial for Lutherans Sells 88,880 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Expert Advice: Fulfilling the potential of bottom-up proteomics - Drug Discovery News
Clearbridge Investments LLC Has $29.50 Million Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
The three-year earnings decline has likely contributed toAzenta's (NASDAQ:AZTA) shareholders losses of 53% over that period - Simply Wall St
Susquehanna Fundamental Investments LLC Grows Stock Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Evercore ISI Lowers Azenta (NASDAQ:AZTA) Price Target to $50.00 - MarketBeat
Sei Investments Co. Raises Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Short Interest in Azenta, Inc. (NASDAQ:AZTA) Rises By 5.3% - MarketBeat
Azenta Selected To Provide Comprehensive Proteomic Profiling for Population Scale Personalized Medicine Project - Technology Networks
Systematic Financial Management LP Reduces Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Intech Investment Management LLC Invests $609,000 in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Financial Metrics Exploration: Understanding Azenta Inc (AZTA) Through Ratios - The Dwinnex
Envestnet Asset Management Inc. Sells 66,651 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Increases Stake in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
AstraZeneca PLC (NASDAQ:AZN) Stock Position Increased by Callan Capital LLC - Defense World
Is Azenta Inc (AZTA) worth investing in despite its overvalued state? - US Post News
AstraZeneca (LSE:AZN) Gains FDA Approval for Fasenra in EGPA, Boosting Revenue Growth and Market Position - Yahoo Finance UK
Rhumbline Advisers Lowers Stake in AstraZeneca PLC (NASDAQ:AZN) - Defense World
IBD Rating Upgrades: AZEK Shows Improved Technical Strength - Investor's Business Daily
AstraZeneca India to launch Palivizumab in Oct 2024, stocks trade flat - BusinessLine
Vanguard Personalized Indexing Management LLC Increases Stake in AstraZeneca PLC (NASDAQ:AZN) - Defense World
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Hsbc Holdings PLC - Defense World
Axxcess Wealth Management LLC Cuts Holdings in AstraZeneca PLC (NASDAQ:AZN) - Defense World
Azenta Inc (AZTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):